Concepedia

David Eichenbaum

DE

24

Publications

1.4K

Citations

17

H-Index

2014

Active since

Affiliations

Retina Vitreous Associates of Florida(Current)

Retina Consultants of Texas

University of South Florida

University of Nevada, Reno

Sierra Eye Associates

David Eichenbaum is an author at Retina Vitreous Associates of Florida specializing in medicine, ophthalmology, and age-related diseases.

Top concepts

MedicineOphthalmologyAge-related DiseasesEye TrackingClinical TrialsPharmacotherapyDiabetic RetinopathyRheumatoid ArthritisClinical EpidemiologyHealth

Publications per year

2014–2025

24

Publications

24

Efficacy and safety of avacincaptad pegol in patients with geographic atrophy (GATHER2): 12-month results from a randomised, double-masked, phase 3 trial

Arshad M. Khanani, Sunil Patel, Giovanni Staurenghi et al. · The Lancet · 2023 · 263 citations · Full text

Clinical Epidemiology, Clinical Trials, Geographic Atrophy +5

Intravitreal aflibercept 8 mg in neovascular age-related macular degeneration (PULSAR): 48-week results from a randomised, double-masked, non-inferiority, phase 3 trial

Paolo Lanzetta, Jean‐François Korobelnik, Jeffrey S. Heier et al. · The Lancet · 2024 · 179 citations

Translational Medicine, Ocular Disease, Ophthalmology +5

TENAYA and LUCERNE

Arshad M. Khanani, Aachal Kotecha, Andrew Chang et al. · Ophthalmology · 2024 · 124 citations · Full text

Avacincaptad pegol for geographic atrophy secondary to age-related macular degeneration: 18-month findings from the GATHER1 trial

Sunil Patel, David R. Lally, Jason Hsu et al. · Eye · 2023 · 118 citations · Full text

Faricimab Treat-and-Extend for Diabetic Macular Edema

Tien Yin Wong, Zdenka Hašková, Kemal Asik et al. · Ophthalmology · 2023 · 105 citations · Full text

Faricimab Treat-and-extend, Diabetic Retinopathy, Ocular Disease +3

Rows per page

1–5 of 24